Most Recent
AstraZeneca probes Pharmacor’s delayed defence in Forxiga patent fight
Pharmacor is resisting AstraZeneca’s notice to produce in an intellectual property fight over diabetes drug Forxiga, claiming privilege over material evidencing its consideration of a new claim challenging the validity of a patent extension.
Construction PRO
Someva wind farm approved after ‘unnecessary’ 18-month council fight
A court has signed off on Someva Renewables' plan to build 62 wind turbines just outside of Hanging Rock following what the company called 18 months of "unnecessary" opposition from a local council that did little to alter the project. 
Judge approves orders bringing Banksia receivership to an end
A judge has approved orders bringing the receivership of Banksia Securities to an end, with the special receiver opting to not pursue $650,000 in costs against Victorian debenture holders who dropped their case alleging breaches to the scandal-ridden class action.
Pharmacor targets patent extension in fight over AstraZeneca’s Forxiga
Pharmacor wants to amend its defence in AstraZeneca's suit over the Australian drug maker's plans to launch a generic version of diabetes drug Forxiga so that it can argue a patent extension for the drug should not have been granted.
Construction PRO
Sydney council pushes for broad ‘public purpose’ in land grab spat
A Sydney council will argue its compulsory acquisition of two properties in Rouse Hill was part of a broader urban development public purpose, rather than the narrower purpose provided in its acquisition notice.
Construction PRO
National Storage wins row over ‘box-like’ Wyndham Vale development
A tribunal has overturned a council decision which rejected National Storage’s proposal to build a two-storey storage facility and box shop in a rapidly expanding suburb in Melbourne’s south west. 
Construction PRO
Castleway in appeal win over payments in development deal with TPC Group
Property developer Castleway has succeeded in its challenge to a ruling limiting its payment entitlements under a development agreement with TPC Group.
Despite flight risk concerns, Shield-linked director can leave Australia
A former director of two marketing companies linked to the failed Shield and First Guardian funds can leave Australia for 12 days, despite ASIC’s concerns he is a flight risk.
Strongroom AI director claims self-incrimination privilege in EVP case
A director of med tech start-up Strongroom AI is claiming privilege against self-incrimination in a case by venture capital firm EVP seeking to recoup its $10.4 million investment.
Ex-CBA exec denies bullying, says swearing ‘commonplace’ at bank
A sacked property finance executive at CBA, who told an unnamed person in the workplace to “calm the f*** down”, has denied his conduct amounted to bullying, claiming swearing was common among his colleagues.